<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html>
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>Breast cancinoma</title>
<link rel="stylesheet" type="text/css" href="view.css" media="all">
<script type="text/javascript" src="view.js"></script>
<script>
function updateDescription (frm) 
{
    var Template = "";
	
/*
if (frm.A01.value !== ""){
	Template += "- Procedure: " + "\n" + frm.A01.value + "\n";
}

if (frm.A02.value !== ""){
	Template += "- Laterality: " + "\n" + frm.A02.value + "\n";
}

if (document.getElementById("A03").checked || document.getElementById("A04").checked || 
    document.getElementById("A05").checked || document.getElementById("A06").checked || 
	document.getElementById("A07").checked || document.getElementById("A08").checked || 
	document.getElementById("A09").checked || document.getElementById("A10").checked || 
	document.getElementById("A11").checked){
	Template += "- Tumor site: " + "\n";
}

if (document.getElementById("A03").checked){
	Template += frm.A03.value + "\n";
}

if (document.getElementById("A04").checked){
	Template += frm.A04.value + "\n";
}

if (document.getElementById("A05").checked){
	Template += frm.A05.value + "\n";
}

if (document.getElementById("A06").checked){
	Template += frm.A06.value + "\n";
}

if (document.getElementById("A07").checked){
	Template += frm.A07.value + "\n";
}

if (document.getElementById("A08").checked){
	Template += frm.A08.value + "\n";
}

if (document.getElementById("A09").checked){
	Template += frm.A09.value + "\n";
}

if (document.getElementById("A10").checked){
	Template += frm.A10.value + "\n";
}

if (document.getElementById("A11").checked){
	Template += frm.A11.value + "\n";
}

if (frm.A12.value !== ""){
	Template += "- Tumor size: " + "\n" + frm.A12.value + "\n";
}
*/
if (frm.A13.value !== ""){
	Template += "- Tumor histology and immunohistochemical studies: " + "\n" + "  - " + frm.A13.value + "\n";
}

if (frm.A14.value !== ""){
	Template += "\n" + "- Histologic type (WHO 2019): " + frm.A14.value + "\n";
}

if (frm.A15.value !== ""){
	Template += "- Tumor focality: " + frm.A15.value + "\n";
}

if (frm.A19.value !== ""){
	Template += "- Histologic grade: " + frm.A19.value + "\n";
}

if (frm.A16.value !== ""){
	Template += "  - Glandular (acinar)/tubular differentiation: " + frm.A16.value + "\n";
}

if (frm.A17.value !== ""){
	Template += "  - Nuclear pleomorphism: " + frm.A17.value + "\n";
}

if (frm.A18.value !== ""){
	Template += "  - Mitotic rate (adjusted to 22 mm eyepiece, 40x objective): " + frm.A18.value + "\n";
}

if (frm.A20.value !== ""){
	Template += "- Ductal carcinoma in situ: " + frm.A20.value + "\n";
}

if (frm.A21.value !== ""){
	Template += "  - Size of DCIS (mm x mm x mm): " + frm.A21.value + "\n";
}

if (frm.A22.value !== ""){
	Template += "  - Number of blocks with DCIS: " + frm.A22.value + "\n";
}

if (frm.A23.value !== ""){
	Template += "  - Number of blocks examined: " + frm.A23.value + "\n";
}

if (document.getElementById("A24").checked || document.getElementById("A25").checked || 
    document.getElementById("A26").checked || document.getElementById("A27").checked || 
	document.getElementById("A28").checked || document.getElementById("A29").checked || 
	document.getElementById("A30").checked){
	Template += "  - Architectural patterns of ductal carcinoma in situ: " + "\n";
}

if (document.getElementById("A24").checked){
	Template += "  " + frm.A24.value + "\n";
}

if (document.getElementById("A25").checked){
	Template += "  " + frm.A25.value + "\n";
}

if (document.getElementById("A26").checked){
	Template += "  " + frm.A26.value + "\n";
}

if (document.getElementById("A27").checked){
	Template += "  " + frm.A27.value + "\n";
}

if (document.getElementById("A28").checked){
	Template += "  " + frm.A28.value + "\n";
}

if (document.getElementById("A29").checked){
	Template += "  " + frm.A29.value + "\n";
}

if (document.getElementById("A30").checked){
	Template += "  " + frm.A30.value + "\n";
}

if (frm.A31.value !== ""){
	Template += "  - Nuclear grade: " + frm.A31.value + "\n";
}

if (frm.A32.value !== ""){
	Template += "  - Necrosis: " + frm.A32.value + "\n";
}

if (frm.A33.value !== ""){
	Template += "- Lobular carcinoma in situ: " + frm.A33.value + "\n";
}

if (frm.A34.value !== ""){
	Template += "- Tumor extension, skin: " + frm.A34.value + "\n";
}

if (frm.A35.value !== ""){
	Template += "- Tumor extension, nipple: " + frm.A35.value + "\n";
}

if (frm.A36.value !== ""){
	Template += "- Tumor extension, skeletal muscle: " + frm.A36.value + "\n";
}

if (frm.A37.value !== ""){
	Template += "- Lymphovascular invasion: " + frm.A37.value + "\n";
}

if (frm.A38.value !== ""){
	Template += "- Dermal lymphovascular invasion: " + frm.A38.value + "\n";
}

if (frm.A39.value !== ""){
	Template += "- Perineural invasion: " + frm.A39.value + "\n";
}

if (frm.A40.value !== ""){
	Template += "- Treatment effect in the breast: " + frm.A40.value + "\n";
}

if (frm.A41.value !== ""){
	Template += "- Treatment effect in the lymph nodes: " + frm.A41.value + "\n";
}

if (frm.A88.value + frm.A89.value + frm.A90.value + frm.A91.value + frm.A92.value + 
    frm.A93.value + frm.A94.value !== ""){
	Template += "- Residual Cancer Burden: " + "\n";
}

if (frm.A88.value !== ""){
	Template += "  - Score: " + frm.A88.value + "\n";
}

if (frm.A89.value !== ""){
	Template += "  - Class: " + frm.A89.value + "\n";
}

if (frm.A90.value !== ""){
	Template += "    - Primary tumor area (mm x mm): " + frm.A90.value + "\n";
}

if (frm.A91.value !== ""){
	Template += "    - Overall cancer cellularity (area %): " + frm.A91.value + "\n";
}

if (frm.A92.value !== ""){
	Template += "    - in situ disesae (area %): " + frm.A92.value + "\n";
}

if (frm.A93.value !== ""){
	Template += "    - No. of positive lymph nodes: " + frm.A93.value + "\n";
}

if (frm.A94.value !== ""){
	Template += "    - Largest LN metastasis (mm): " + frm.A94.value + "\n";
}

if (document.getElementById("A66").checked || document.getElementById("A67").checked || 
    document.getElementById("A68").checked || document.getElementById("A69").checked || 
	document.getElementById("A70").checked || document.getElementById("A71").checked){
	Template += "- Microcalcifications: " + "\n";
}

if (document.getElementById("A66").checked){
	Template += frm.A66.value + "\n";
}

if (document.getElementById("A67").checked){
	Template += frm.A67.value + "\n";
}

if (document.getElementById("A68").checked){
	Template += frm.A68.value + "\n";
}

if (document.getElementById("A69").checked){
	Template += frm.A69.value + "\n";
}

if (document.getElementById("A70").checked){
	Template += frm.A70.value + "\n";
}

if (document.getElementById("A71").checked){
	Template += frm.A71.value + "\n";
}

if (frm.A42.value !== ""){
	Template += "\n" + "- Surgical margin for invasive tumor:" + "\n" + "  - Anterior: " + frm.A42.value + "\n";
}

if (frm.A43.value !== ""){
	Template += "  - Posterior: " + frm.A43.value + "\n";
}

if (frm.A44.value !== ""){
	Template += "  - Superior: " + frm.A44.value + "\n";
}

if (frm.A45.value !== ""){
	Template += "  - Inferior: " + frm.A45.value + "\n";
}

if (frm.A46.value !== ""){
	Template += "  - Medial: " + frm.A46.value + "\n";
}

if (frm.A47.value !== ""){
	Template += "  - Lateral: " + frm.A47.value + "\n";
}

if (frm.A48.value !== ""){
	Template += "  - Other (specify): " + frm.A48.value + "\n";
}
	
if (frm.A81.value !== ""){
	Template += "\n" + "- Surgical margin for DCIS:" + "\n" + "  - Anterior: " + frm.A81.value + "\n";
}

if (frm.A82.value !== ""){
	Template += "  - Posterior: " + frm.A82.value + "\n";
}

if (frm.A83.value !== ""){
	Template += "  - Superior: " + frm.A83.value + "\n";
}

if (frm.A84.value !== ""){
	Template += "  - Inferior: " + frm.A84.value + "\n";
}

if (frm.A85.value !== ""){
	Template += "  - Medial: " + frm.A85.value + "\n";
}

if (frm.A86.value !== ""){
	Template += "  - Lateral: " + frm.A86.value + "\n";
}

if (frm.A87.value !== ""){
	Template += "  - Other (specify): " + frm.A87.value + "\n";
}

if (frm.A49.value + frm.A50.value + frm.A51.value + frm.A52.value + frm.A53.value + 
    frm.A54.value + frm.A55.value + frm.A56.value !== ""){
	Template += "\n" + "- Lymph nodes examination: " + "\n";
}	

if (frm.A49.value !== ""){
	Template += "  - Number of regional lymph nodes examined: " + frm.A49.value + "\n";
}

if (frm.A50.value !== ""){
	Template += "  - Number of sentinel lymph nodes examined: " + frm.A50.value + "\n";
}

if (frm.A51.value !== ""){
	Template += "  - Number of lymph nodes with macrometastasis (> 2 mm): " + frm.A51.value + "\n";
}

if (frm.A52.value !== ""){
	Template += "  - Number of lymph nodes with micrometastasis (> 0.2 to 2 mm and/or > 200 cells): " + frm.A52.value + "\n";
}

if (frm.A53.value !== ""){
	Template += "  - Number of lymph nodes with isolated tumor cells (0.2 mm or less and < or = 200 cells): " + frm.A53.value + "\n";
}

if (frm.A54.value !== ""){
	Template += "  - Size of largest metastatic deposit (mm), specify site: " + frm.A54.value + "\n";
}

if (frm.A55.value !== ""){
	Template += "  - Size of largest lymph node involved (mm), specify site: " + frm.A55.value + "\n";
}

if (frm.A56.value !== ""){
	Template += "  - Extranodal extension (ENE) : " + frm.A56.value + "\n";
}

if (document.getElementById("A72").checked || document.getElementById("A73").checked ||
	document.getElementById("A74").checked || document.getElementById("A75").checked ||
	document.getElementById("A76").checked || document.getElementById("A77").checked ||
	document.getElementById("A78").checked || document.getElementById("A79").checked ||
    document.getElementById("A80").checked){
	Template += "\n" + "- Distant metastasis:" + "\n";
}

if (document.getElementById("A72").checked){
	Template += frm.A72.value + "\n";
}

if (document.getElementById("A73").checked){
	Template += frm.A73.value + "\n";
}

if (document.getElementById("A74").checked){
	Template += frm.A74.value + "\n";
}

if (document.getElementById("A75").checked){
	Template += frm.A75.value + "\n";
}

if (document.getElementById("A76").checked){
	Template += frm.A76.value + "\n";
}

if (document.getElementById("A77").checked){
	Template += frm.A77.value + "\n";
}

if (document.getElementById("A78").checked){
	Template += frm.A78.value + "\n";
}

if (document.getElementById("A79").checked){
	Template += frm.A79.value + "\n";
}

if (document.getElementById("A80").checked){
	Template += frm.A80.value + "\n";
}

if (document.getElementById("A57").checked || document.getElementById("A58").checked ||
    document.getElementById("A59").checked || document.getElementById("A61").checked || 
	document.getElementById("A62").checked || frm.A60.value + frm.A63.value + 
	frm.A64.value){
	Template += "\n" + "- Pathologic stage classification (pTNM, AJCC 8th edition):" + "\n";
}

if (document.getElementById("A57").checked || document.getElementById("A58").checked ||
    document.getElementById("A59").checked){
	Template += "  - TNM Descriptors:" + "\n";
}

if (document.getElementById("A57").checked){
	Template += "    " + frm.A57.value + "\n";
}

if (document.getElementById("A58").checked){
	Template += "    " + frm.A58.value + "\n";
}

if (document.getElementById("A59").checked){
	Template += "    " +frm.A59.value + "\n";
}

if (frm.A60.value !== ""){
	Template += "  - Primary tumor (pT): " + "\n" + "  " + frm.A60.value + "\n";
}

if (document.getElementById("A61").checked || document.getElementById("A62").checked){
	Template += "  - Regional lymph nodes modifier:" + "\n";
}

if (document.getElementById("A61").checked){
	Template += "    " + frm.A61.value + "\n";
}

if (document.getElementById("A62").checked){
	Template += "    " + frm.A62.value + "\n";
}

if (frm.A63.value !== ""){
	Template += "  - Regional lymph nodes (pN): " + "\n" + "  " + frm.A63.value + "\n";
}

if (frm.A64.value !== ""){
	Template += "  - Distant metastasis: " + "\n" + "  " + frm.A64.value + "\n";
}

/**
if (frm.A65.value !== ""){
	Template += "    - Specify site(s): " + frm.A65.value + "\n";
}
**/

if (frm.A66.value !== ""){
	Template += "\n" + "- Additional notes: " + "\n" +  frm.A66.value + "\n";
}

frm.holdtext.value = Template;
}

function CopyToClipboard() {
  /* Get the text field */
  var copyText = document.getElementById("holdtext");

  /* Select the text field */
  copyText.select();

  /* Copy the text inside the text field */
  document.execCommand("copy");

  /* Alert the copied text */
  alert("Report copied to clipboard");
}
</script>
<style>
table, th, td {
  border: 1px solid silver;
  border-collapse: collapse;
  padding: 4px;
}
</style>
</head>

<body>
<img id="top" src="top.png" alt="">
	<div id="form_container">
	<div class="form_description">
		<h2><a href=".\cap\Cancer-Protocols-2024-06-Update\Breast Protocol Folder\Breast.Invasive_4.10.0.0.REL.CAPCP.pdf" target="_blank">
		<div class="tooltip">Invasive carcinoma of the breast
		<span class="tooltiptext">click to access explanations in the original CAP template</span>
		</div>
		</a></h2>
	</div>
	
<form>
<p>
There is different protocol for <a href=".\cap\Cancer-Protocols-2023-03-Update\Breast Protocol Folder\Breast.Invasive.Bx_1.2.0.0.REL_CAPCP.pdf" target="_blank">biopsy specimen</a>
</p>

<p>
<a href=".\cap\Cancer-Protocols-2023-03-Update\Breast Protocol Folder\Breast.Bmk_1.5.0.1.REL_CAPCP.pdf" target="_blank">Biomarker notes</a> are updated.
</p>

<!--
<fieldset style="border-color:#e6e6ff;">
	<legend><label class="description">Gross descriptions:</label></legend>

<p>
<table border="1">
<col width="40%">

<tr>
<td>
<label class="description">- Procedure:</label>
</td>
<td>
	<select class="element select large" ID="A01">
		<option value=""></option>
		<option value="  - Excision (less than total mastectomy)">Excision (less than total mastectomy)</option> 
		<option value="  - Total mastectomy (including nipple-sparing and skin-sparing mastectomy)">Total mastectomy (including nipple-sparing and skin-sparing mastectomy)</option>
		<option value="  - Other (specify):">Other (specify):</option>
		<option value="  - Not specified">Not specified</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- Specimen laterality:</label>
</td>
<td>
	<select class="element select large" ID="A02">
		<option value=""></option>
		<option value="  - Right">Right</option> 
		<option value="  - Left">Left</option>
		<option value="  - Not specified">Not specified</option>
	</select>
</td>
</tr>

<tr>
<td valign="top">
<label class="description">- Tumor site:</label> 
</td>
<td>
	<input class="element checkbox" type="checkbox" id="A03" value="  - Upper outer quadrant"><label>Upper outer quadrant</label><br>
	<input class="element checkbox" type="checkbox" id="A04" value="  - Lower outer quadrant"><label>Lower outer quadrant</label><br>
	<input class="element checkbox" type="checkbox" id="A05" value="  - Upper inner quadrant"><label>Upper inner quadrant</label><br>
	<input class="element checkbox" type="checkbox" id="A06" value="  - Lower inner quadrant"><label>Lower inner quadrant</label><br>
	<input class="element checkbox" type="checkbox" id="A07" value="  - Central"><label>Central</label><br>
	<input class="element checkbox" type="checkbox" id="A08" value="  - Nipple"><label>Nipple</label><br>
	<input class="element checkbox" type="checkbox" id="A09" value="  - Position (specify): o’clock"><label>Position (specify): o’clock</label><br>
	<input class="element checkbox" type="checkbox" id="A10" value="  - Other (specify):"><label>Other (specify):</label><br>
	<input class="element checkbox" type="checkbox" id="A11" value="  - Not specified"><label>Not specified</label><br>
</td>
</tr>

<tr>
<td>
<label class="description">- Tumor size:</label> 
</td>
<td>
	<select class="element select large" ID="A12">
		<option value=""></option>
		<option value="  - Microinvasion only (< or = 1 mm)">Microinvasion only (< or = 1 mm)</option>
		<option value="  - Greatest dimension (mm): ">Greatest dimension (mm): </option>
		<option value="  - All dimensions (mm x mm x mm): ">All dimensions (mm x mm x mm):</option>
		<option value="  - No residual carcinoma">No residual carcinoma</option>
		<option value="  - Cannot be determined (explain):">Cannot be determined (explain):</option>
	</select>
</td>
</tr>
</table>
</p>
</fieldset>
</p>
-->

<p>
<fieldset style="border-color:#e6e6ff;">
	<legend><label class="description">Microscopic descriptions:</label></legend>
<p>
<label class="description">- Tumor histology and immunohistochemical studies: </label>
	<textarea ID="A13" class="element textarea medium"></textarea>
</p>

<p>
<table border="1">
<col width="40%">

<tr>
<td>
<label class="description">- <a href=".\cap\Cancer-Protocols-2022-03-Update\Breast Protocol Folder\Breast.Invasive_4.6.0.0.REL_CAPCP.pdf#page=20" target="_blank">Histologic type (2019)</a>:</label> 
</td>
<td>
	<select class="element select large" ID="A14">
		<option value=""></option>
		<option value="No residual invasive carcinoma">No residual invasive carcinoma</option>
		<option value="Invasive carcinoma of no special type (ductal)">Invasive carcinoma of no special type (ductal)</option>
		<option value="Micro-invasive carcinoma">Micro-invasive carcinoma</option>
		<option value="Invasive lobular carcinoma">Invasive lobular carcinoma</option>
		<option value="Invasive carcinoma with ductal and lobular features (mixed type carcinoma)">Invasive carcinoma with ductal and lobular features (mixed type carcinoma)</option>
		<option value="Invasive breast carcinoma with medullary pattern">Invasive breast carcinoma with medullary pattern</option>
		<option value="Invasive carcinoma with features of (specify): ">Invasive carcinoma with features of (specify): </option>
		<option value="Tubular carcinoma">Tubular carcinoma</option>
		<option value="Invasive cribriform carcinoma">Invasive cribriform carcinoma</option>
		<option value="Mucinous carcinoma">Mucinous carcinoma</option>
		<option value="Invasive micropapillary carcinoma">Invasive micropapillary carcinoma</option>
		<option value="Apocrine adenocarcinoma">Apocrine adenocarcinoma</option>
		<option value="Metaplastic carcinoma">Metaplastic carcinoma</option>
		<option value="Encapsulated papillary carcinoma with invasion">Encapsulated papillary carcinoma with invasion</option>	
		<option value="Solid papillary carcinoma with invasiona">Solid papillary carcinoma with invasion</option>	
		<option value="Intraductal papillary adenocarcinoma with invasion">Intraductal papillary adenocarcinoma with invasion</option>
		<option value="Adenoid cystic carcinoma">Adenoid cystic carcinoma</option>
		<option value="Neuroendocrine tumor">Neuroendocrine tumor</option>
		<option value="Neuroendocrine carcinoma">Neuroendocrine carcinoma</option>
		<option value="Invasive carcinoma, type cannot be determined">Invasive carcinoma, type cannot be determined</option>
		<option value="Other (specify):">Other (specify):</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class=""> + <a href=".\cap\Cancer-Protocols-2022-03-Update\Breast Protocol Folder\Breast.Invasive_4.6.0.0.REL_CAPCP.pdf#page=25" target="_blank">Tumor focality</a>:</label>
</td>
<td>
	<select class="element select large" ID="A15">
		<option value=""></option>
		<option value="Single focus of invasive carcinoma">Single focus of invasive carcinoma</option> 
		<option value="Multiple foci of invasive carcinoma, specify no. and sizes:">Multiple foci of invasive carcinoma, specify no. and sizes</option>
		<option value="Cannot be determined">Cannot be determined</option>
	</select>
</td>
</tr>

<tr>
<td rowspan="4" valign="top">
<label class="description">- <a href=".\cap\Cancer-Protocols-2022-03-Update\Breast Protocol Folder\Breast.Invasive_4.6.0.0.REL_CAPCP.pdf#page=21" target="_blank">Histologic grade (Nottingham)</a> :</label>
</td>
<td>
	<select class="element select large" ID="A19">
		<option value=""></option>
		<option value="Grade 1 (scores of 3, 4, or 5)">Grade 1 (scores of 3, 4, or 5)</option>
		<option value="Grade 2 (scores of 6 or 7)">Grade 2 (scores of 6 or 7)</option>
		<option value="Grade 3 (scores of 8 or 9)">Grade 3 (scores of 8 or 9)</option>
		<option value="Only microinvasion present (not graded)">Only microinvasion present (not graded)</option>
		<option value="No residual invasive carcinoma">No residual invasive carcinoma</option>
		<option value="Score cannot be determined">Score cannot be determined</option>
	</select>
</td>
</tr>

<tr>
<td align="right">
<label>- Glandular (acinar)/tubular differentiation :</label>
	<select class="element select small" ID="A16">
		<option value=""></option>
		<option value="Score 1 (>75% of tumor area forming glandular/tubular structures)">Score 1 (>75% of tumor area forming glandular/tubular structures)</option>
		<option value="Score 2 (10% to 75% of tumor area forming glandular/tubular structures)">Score 2 (10% to 75% of tumor area forming glandular/tubular structures)</option>
		<option value="Score 3 (<10% of tumor area forming glandular/tubular structures)">Score 3 (<10% of tumor area forming glandular/tubular structures)</option>
		<option value="Only microinvasion present (not graded)">Only microinvasion present (not graded)</option>
		<option value="No residual invasive carcinoma">No residual invasive carcinoma</option>
		<option value="Score cannot be determined">Score cannot be determined</option>
	</select>
</td>
</tr>

<tr>
<td align="right">
<label>- Nuclear pleomorphism :</label>
	<select class="element select small" ID="A17">
		<option value=""></option>
		<option value="Score 1 (nuclei small with little increase in size in comparison with normal breast epithelial cells, regular outlines, uniform nuclear chromatin, little variation in size)">Score 1 (nuclei small with little increase in size in comparison with normal breast epithelial cells, regular outlines, uniform nuclear chromatin, little variation in size)</option>
		<option value="Score 2 (cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)">Score 2 (cells larger than normal with open vesicular nuclei, visible nucleoli, and moderate variability in both size and shape)</option>
		<option value="Score 3 (vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and shape, occasionally with very large and bizarre forms)">Score 3 (vesicular nuclei, often with prominent nucleoli, exhibiting marked variation in size and shape, occasionally with very large and bizarre forms)</option>
		<option value="Only microinvasion present (not graded)">Only microinvasion present (not graded)</option>
		<option value="No residual invasive carcinoma">No residual invasive carcinoma</option>
		<option value="Score cannot be determined">Score cannot be determined</option>
	</select>
</td>
</tr>

<tr>
<td align="right">
<label>- Mitotic rate (22 mm eyepiece, 40x) :</label>
	<select class="element select small" ID="A18">
		<option value=""></option>
		<option value="Score 1 (< or = 8 mitoses per 10 hpf), specify:">Score 1 (< or = 8 mitoses per 10 hpf)</option>
		<option value="Score 2 (9-17 mitoses per 10 hpf), specify:">Score 2 (9-17 mitoses per 10 hpf)</option>
		<option value="Score 3 (> or = 18 mitoses per 10 hpf), specify:">Score 3 (> or = 18 mitoses per 10 hpf)</option>
		<option value="Only microinvasion present (not graded)">Only microinvasion present (not graded)</option>
		<option value="No residual invasive carcinoma">No residual invasive carcinoma</option>
		<option value="Score cannot be determined">Score cannot be determined</option>
	</select>
</td>
</tr>

<tr>
<td rowspan="4" valign="top">
<label class="description">- <a href=".\cap\Cancer-Protocols-2022-03-Update\Breast Protocol Folder\Breast.Invasive_4.6.0.0.REL_CAPCP.pdf#page=30" target="_blank">Tumor extension</a>:</label>
</td>
</tr>
<tr>
<td align="right">
<label>- Skin :</label>
	<select class="element select medium" ID="A34">
		<option value=""></option>
		<option value="Skin is not present">Skin is not present</option>
		<option value="Skin is present and uninvolved">Skin is present and uninvolved</option>
		<option value="Invasive carcinoma directly invades into the dermis or epidermis without skin ulceration (this does not change the T stage)">Invasive carcinoma directly invades into the dermis or epidermis without skin ulceration (this does not change the T stage)</option>
		<option value="Invasive carcinoma directly invades into the dermis or epidermis with skin ulceration (classified as T4b)">Invasive carcinoma directly invades into the dermis or epidermis with skin ulceration (classified as T4b)</option>
		<option value="Satellite skin foci of invasive carcinoma are present (ie, not contiguous with the invasive carcinoma in the breast) (classified as T4b)">Satellite skin foci of invasive carcinoma are present (ie, not contiguous with the invasive carcinoma in the breast) (classified as T4b)</option>
	</select>
</td>
</tr>

<tr>
<td align="right">
<label>- Nipple :</label>
	<select class="element select medium" ID="A35">
		<option value=""></option>
		<option value="Nipple is not present">Nipple is not present</option>
		<option value="DCIS does not involve the nipple epidermis">DCIS does not involve the nipple epidermis </option>
		<option value="DCIS involves nipple epidermis (Paget disease of the nipple)">DCIS involves nipple epidermis (Paget disease of the nipple)</option>
	</select>
</td>
</tr>

<tr>
<td align="right">
<label>- Skeletal muscle :</label>
	<select class="element select medium" ID="A36">
		<option value=""></option>
		<option value="Skeletal muscle is not present">Skeletal muscle is not present</option>
		<option value="Skeletal muscle is present and uninvolved">Skeletal muscle is present and uninvolved</option>
		<option value="Carcinoma invades skeletal muscle">Carcinoma invades skeletal muscle</option>
		<option value="Carcinoma invades into skeletal muscle and into the chest wall (classified as T4a)">Carcinoma invades into skeletal muscle and into the chest wall (classified as T4a)</option>
	</select>
</td>
</tr>


<tr>
<td>
<label class="description">- <a href=".\cap\Cancer-Protocols-2023-06-Update\Breast Protocol Folder\Breast.Invasive_4.9.0.0.REL_CAPCP.pdf#page=34" target="_blank">Lymphatic and/or vascular invasion</a>: </label>
</td>
<td>
	<select class="element select large" ID="A37">
		<option value=""></option>
		<option value="Not identified">Not identified</option>
		<option value="Present">Present</option>
		<option value="Present, Focal (LVI in one block only)">Present, Focal (LVI in one block only)</option>
		<option value="Present, Extensive (LVI in two or more blocks)">Present, Extensive (LVI in two or more blocks)</option>
		<option value="Cannot be determined">Cannot be determined</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="">+ Dermal lymphatic and/or vascular invasion: </label>
</td>
<td>
	<select class="element select large" ID="A38">
		<option value=""></option>
		<option value="Not identified">Not identified</option>
		<option value="Present">Present</option>
		<option value="Cannot be determined">Cannot be determined</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="">+ Perineural invasion: </label>
</td>
<td>
	<select class="element select large" ID="A39">
		<option value=""></option>
		<option value="Not identified">Not identified</option>
		<option value="Present">Present</option>
		<option value="Cannot be determined">Cannot be determined</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- <a href=".\cap\Cancer-Protocols-2022-03-Update\Breast Protocol Folder\Breast.Invasive_4.6.0.0.REL_CAPCP.pdf#page=33" target="_blank">Treatment effect in the breast</a>: </label>
</td>
<td>
	<select class="element select large" ID="A40">
		<option value=""></option>
		<option value="No known presurgical therapy">No known presurgical therapy</option>
		<option value="No definite response to presurgical therapy in the invasive carcinoma">No definite response to presurgical therapy in the invasive carcinoma</option>
		<option value="Probable or definite response to presurgical therapy in the invasive carcinoma">Probable or definite response to presurgical therapy in the invasive carcinoma</option>
		<option value="No residual invasive carcinoma is present in the breast after presurgical therapy">No residual invasive carcinoma is present in the breast after presurgical therapy</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- <a href=".\cap\Cancer-Protocols-2022-03-Update\Breast Protocol Folder\Breast.Invasive_4.6.0.0.REL_CAPCP.pdf#page=37" target="_blank">Treatment effect in LN</a>: </label>
</td>
<td>
	<select class="element select large" ID="A41">
		<option value=""></option>
		<option value="No known presurgical therapy">No known presurgical therapy</option>
		<option value="No definite response to presurgical therapy in metastatic carcinoma">No definite response to presurgical therapy in metastatic carcinoma</option>
		<option value="Probable or definite response to presurgical therapy in metastatic carcinoma">Probable or definite response to presurgical therapy in metastatic carcinoma</option>
		<option value="No lymph node metastases. Fibrous scarring or histiocytic aggregates, possibly related to prior lymph node metastases with pathologic complete response">No lymph node metastases. FFibrous scarring or histiocytic aggregates, possibly related to prior lymph node metastases with pathologic complete response</option>
		<option value="No lymph node metastases and no fibrous scarring or histiocytic aggregates in the nodes">No lymph node metastases and no fibrous scarring or histiocytic aggregates in the nodes</option>
	</select>
</td>
</tr>

<tr>
<td rowspan="8" valign="top">
<label>+ <a href=".\cap\Cancer-Protocols-2024-06-Update\Breast Protocol Folder\Breast.Invasive_4.10.0.0.REL.CAPCP.pdf#page=35" target="_blank">Residual Cancer Burden</a>: </label>
<br>
<a href="http://www3.mdanderson.org/app/medcalc/index.cfm?pagename=jsconvert3" target="blank">MD Anderson Calculator</a><br>
1. Primary tumor bed area<br>
2. Lymph node<br>
<a href=".\cap\Cancer-Protocols-2023-06-Update\Breast Protocol Folder\PLM_protocol_RCB_calculators_BRO.pdf" target="_blank">Protocol</a><br>
<a href=".\cap\Cancer-Protocols-2023-06-Update\Breast Protocol Folder\jco.2007.10.6823.pdf" target="_blank">Symmans et al. 2007</a>
</td>
</tr>

<tr>
<td align="right">
<label> RCB:</label>
<input type="text" ID="A88" class="element text medium" size="20">
</td>
</tr>

<tr>
<td align="right">
<label> Class:</label>
	<select class="element select medium" ID="A89">
		<option value=""></option>
		<option value="RCB-0 (pCR)">RCB-0 (pCR)</option>
		<option value="RCB-I">RCB-I</option>
		<option value="RCB-II">RCB-II</option>
		<option value="RCB-III">RCB-III</option>
	</select>
</td>
</tr>

<tr>
<td align="right">
<label>Primary tumor bed area (mm x mm) :</label> 
<input type="text" ID="A90" class="element text small" size="20">
</td>
</tr>

<tr>
<td align="right">
<label>Overall cancer cellularity (area%) :</label> 
<input type="text" ID="A91" class="element text small" size="20">
</td>
</tr>

<tr>
<td align="right">
<label>in situ (area%) :</label> 
<input type="text" ID="A92" class="element text small" size="20">
</td>
</tr>

<tr>
<td align="right">
<label>No. of positive LN :</label> 
<input type="text" ID="A93" class="element text small" size="20">
</td>
</tr>

<tr>
<td align="right">
<label>Largest LN metastasis (mm) :</label> 
<input type="text" ID="A94" class="element text small" size="20">
</td>
</tr>

<tr>
<td rowspan="8" valign="top">
<label class="description">- <a href=".\cap\Cancer-Protocols-2022-03-Update\Breast Protocol Folder\Breast.Invasive_4.6.0.0.REL_CAPCP.pdf#page=27" target="_blank">Ductal carcinoma in situ</a>: </label>
</td>
<td>
	<select class="element select large" ID="A20">
		<option value=""></option>
		<option value="Not identified">Not identified</option>
		<option value="Present">Present</option>
		<option value="Present, Negative for extensive intraductal component (EIC)">Present, Negative for extensive intraductal component (EIC)</option>
		<option value="Present, Positive for extensive intraductal component (EIC)">Present, Positive for extensive intraductal component (EIC)</option>
		<option value="Present, Only DCIS is present after presurgical (neoadjuvant) therapy">Present, Only DCIS is present after presurgical (neoadjuvant) therapy</option>
	</select>
</td>
</tr>

<tr>
<td align="right">
<label>+ Size of DCIS (mm x mm x mm) :</label> 
<input type="text" ID="A21" class="element text small" size="20">
</td>
</tr>

<tr>
<td align="right">
+ Number of blocks with DCIS :
<input type="text" ID="A22" class="element text small" size="10">
</td>
</tr>

<tr>
<td align="right">
+ Number of blocks examined :
<input type="text" ID="A23" class="element text small" size="10">
</td>
</tr>

<tr>
<td align="right">
<label>+ Nuclear grade:</label>
	<select class="element select small" ID="A31">
		<option value=""></option>
		<option value="Grade I (low)">Grade I (low)</option>
		<option value="Grade II (intermediate)">Grade II (intermediate)</option>
		<option value="Grade III (high)">Grade III (high)</option>
	</select>
</td>
</tr>

<tr>
<td align="right">
<label>+ Necrosis: </label>
	<select class="element select small" ID="A32">
		<option value=""></option>
		<option value="Not identified">Not identified</option>
		<option value="Present, focal (small foci or single cell necrosis)">Present, focal (small foci or single cell necrosis)</option>
		<option value="Present, central (expansive “comedo” necrosis)">Present, central (expansive “comedo” necrosis)</option>
	</select>
</td>
</tr>

<tr>
<td valign="top">
<label>+ Architectural patterns of ductal carcinoma in situ:</label><br>
	<input class="element checkbox" type="checkbox" id="A24"  value="  - Comedo"><label class="choice" >Comedo</label>
	<input class="element checkbox" class="element checkbox" type="checkbox" id="A25"  value="  - Paget disease (DCIS involving nipple skin)"><label class="choice" >Paget disease</label>
	<input class="element checkbox" class="element checkbox" type="checkbox" id="A26"  value="  - Cribriform"><label class="choice" >Cribriform</label>
	<input class="element checkbox" type="checkbox" id="A27"  value="  - Micropapillary"><label class="choice" >Micropapillary</label>
	<input class="element checkbox" class="element checkbox" type="checkbox" id="A28"  value="  - Papillary"><label class="choice" >Papillary</label>
	<input class="element checkbox" class="element checkbox" type="checkbox" id="A29"  value="  - Solid"><label class="choice" >Solid</label>
	<input class="element checkbox" class="element checkbox" type="checkbox" id="A30"  value="  - Other, specify:"><label class="choice" >Other, specify:</label>

</td>
</tr>

<tr>
<td>
<label>+ Lobular carcinoma in situ:</label>
	<select class="element select medium" ID="A33">
		<option value=""></option>
		<option value="No LCIS in specimen">No LCIS in specimen</option>
		<option value="Present">Present</option>
	</select>
</td>
</tr>

<tr>
<td valign="top">
<label class="">+ <a href=".\cap\Cancer-Protocols-2022-03-Update\Breast Protocol Folder\Breast.Invasive_4.6.0.0.REL_CAPCP.pdf#page=32" target="_blank">Microcalcifications</a>:</label>
</td>
<td>
	<input class="element checkbox" class="element checkbox" type="checkbox" id="A67"  value="  - Not identified"><label class="choice" >Not identified</label>
	<input class="element checkbox" type="checkbox" id="A68"  value="  - Present in DCIS"><label class="choice" >Present in DCIS</label>
	<input class="element checkbox" type="checkbox" id="A69"  value="  - Present in invasive carcinoma"><label class="choice" >Present in invasive carcinoma</label>
	<input class="element checkbox" type="checkbox" id="A70"  value="  - Present in non-neoplastic tissue"><label class="choice" >Present in non-neoplastic tissue</label>
	<input class="element checkbox" type="checkbox" id="A71"  value="  - Other (specify):"><label class="choice" >Other (specify):</label>
</td>
</tr>
</table>
</p>

<p>
+ <a href="Biomarker-Breast-markers.html" target="_blank">Anxillary tests</a> for reporting of ER, PR, Ki-67, HER2 IHC, HER2 DISH and PD-L1.
</p>
</fieldset>
</p>

<p>
<fieldset style="border-color:#e6e6ff;">
<legend><label class="description"><a href=".\cap\Cancer-Protocols-2022-03-Update\Breast Protocol Folder\Breast.Invasive_4.6.0.0.REL_CAPCP.pdf#page=34" target="_blank">Surgical margins for invasive tumor</a> (at least one closest margin): </label></legend>

<p>
<table border="1">
<col width="60%">

<tr>
<td>
<label class="description">- Anterior margin:</label>
</td>
<td>
	<select class="element select large" ID="A42">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by invasive carcinoma, closest distance:">Uninvolved by invasive carcinoma, closest distance:</option>
		<option value="Involved by invasive carcinoima">Involved by invasive carcinoma</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- Posterior margin:</label>
</td>
<td>
	<select class="element select large" ID="A43">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by invasive carcinoma, closest distance:">Uninvolved by invasive carcinoma, closest distance:</option>
		<option value="Involved by invasive carcinoima">Involved by invasive carcinoma</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- Superior margin:</label>
</td>
<td>
	<select class="element select large" ID="A44">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by invasive carcinoma, closest distance:">Uninvolved by invasive carcinoma, closest distance:</option>
		<option value="Involved by invasive carcinoima">Involved by invasive carcinoma</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- Inferior margin:</label>
</td>
<td>
	<select class="element select large" ID="A45">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by invasive carcinoma, closest distance:">Uninvolved by invasive carcinoma, closest distance:</option>
		<option value="Involved by invasive carcinoima">Involved by invasive carcinoma</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- Medial margin:</label>
</td>
<td>
	<select class="element select large" ID="A46">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by invasive carcinoma, closest distance:">Uninvolved by invasive carcinoma, closest distance:</option>
		<option value="Involved by invasive carcinoima">Involved by invasive carcinoma</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- Lateral margin:</label>
</td>
<td>
	<select class="element select large" ID="A47">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by invasive carcinoma, closest distance:">Uninvolved by invasive carcinoma, closest distance:</option>
		<option value="Involved by invasive carcinoima">Involved by invasive carcinoma</option>
	</select>
</td>
</tr>

<tr>
<td>
<label>- Other margins (specify):</label>
</td>
<td>
	<select class="element select large" ID="A48">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by invasive carcinoma, closest distance:">Uninvolved by invasive carcinoma, closest distance:</option>
		<option value="Involved by invasive carcinoima">Involved by invasive carcinoma</option>
	</select>
</td>
</tr>
</table>
</p>
</fieldset>
</p>

<p>
<fieldset style="border-color:#e6e6ff;">
<legend><label class="description"><a href=".\cap\Cancer-Protocols-2022-03-Update\Breast Protocol Folder\Breast.Invasive_4.6.0.0.REL_CAPCP.pdf#page=34" target="_blank">Surgical margins for DCIS</a> (at least one closest margin): </label></legend>

<p>
<table border="1">
<col width="60%">

<tr>
<td>
<label class="description">- Anterior margin:</label>
</td>
<td>
	<select class="element select large" ID="A81">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by DCIS (>2 mm), closest distance:">Uninvolved by DCIS (>2 mm), closest distance:</option>
		<option value="Involved by DCIS, closest distance:">Involved by DCIS, closest distance:</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- Posterior margin:</label>
</td>
<td>
	<select class="element select large" ID="A82">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by DCIS (>2 mm), closest distance:">Uninvolved by DCIS (>2 mm), closest distance:</option>
		<option value="Involved by DCIS, closest distance:">Involved by DCIS, closest distance:</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- Superior margin:</label>
</td>
<td>
	<select class="element select large" ID="A83">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by DCIS (>2 mm), closest distance:">Uninvolved by DCIS (>2 mm), closest distance:</option>
		<option value="Involved by DCIS, closest distance:">Involved by DCIS, closest distance:</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- Inferior margin:</label>
</td>
<td>
	<select class="element select large" ID="A84">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by DCIS (>2 mm), closest distance:">Uninvolved by DCIS (>2 mm), closest distance:</option>
		<option value="Involved by DCIS, closest distance:">Involved by DCIS, closest distance:</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- Medial margin:</label>
</td>
<td>
	<select class="element select large" ID="A85">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by DCIS (>2 mm), closest distance:">Uninvolved by DCIS (>2 mm), closest distance:</option>
		<option value="Involved by DCIS, closest distance:">Involved by DCIS, closest distance:</option>
	</select>
</td>
</tr>

<tr>
<td>
<label class="description">- Lateral margin:</label>
</td>
<td>
	<select class="element select large" ID="A86">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by DCIS (>2 mm), closest distance:">Uninvolved by DCIS (>2 mm), closest distance:</option>
		<option value="Involved by DCIS, closest distance:">Involved by DCIS, closest distance:</option>
	</select>
</td>
</tr>

<tr>
<td>
<label>- Other margins (specify):</label>
</td>
<td>
	<select class="element select large" ID="A87">
		<option value=""></option>
		<option value="Cannot be assessed">Cannot be assessed</option>
		<option value="Uninvolved by DCIS (>2 mm), closest distance:">Uninvolved by DCIS (>2 mm), closest distance:</option>
		<option value="Involved by DCIS, closest distance:">Involved by DCIS, closest distance:</option>
	</select>
</td>
</tr>
</table>
</p>
</fieldset>
</p>

<p>
<fieldset style="border-color:#e6e6ff;">
	<legend> <label class="description"> <a href=".\cap\Cancer-Protocols-2023-06-Update\Breast Protocol Folder\Breast.Invasive_4.9.0.0.REL_CAPCP.pdf#page=38" target="_blank">Regional lymph nodes</a>: </label></legend>

<p>
<table border="1">
<col width="75%">

<tr>
<td>
<label class="description">- Number of regional lymph nodes examined:</label>
</td>
<td>
<input type="text" ID="A49" class="element text large" size="10">
</td>
</tr>

<tr>
<td>
<label class="description">- Number of sentinel lymph nodes examined:</label>
</td>
<td>
<input type="text" ID="A50" class="element text large" size="10">
</td>
</tr>

<tr>
<td>
<label class="description">- Number of lymph nodes with macrometastasis (>2 mm):</label>
</td>
<td>
<input type="text" ID="A51" class="element text large" size="10">
</td>
</tr>

<tr>
<td>
<label class="description">- Number of lymph nodes with micrometastasis <br>(> 0.2 to 2 mm and/or > 200 cells):</label>
</td>
<td>
<input type="text" ID="A52" class="element text large" size="10">
</td>
</tr>

<tr>
<td>
<label class="description">- Number of lymph nodes with isolated tumor cells <br>(0.2 mm or less and < or = 200 cells):</label>
</td>
<td>
<input type="text" ID="A53" class="element text large" size="10">
</td>
</tr>

<tr>
<td>
<label class="description">- Size of largest metastatic deposit (mm), specify site:</label>
</td>
<td>
<input type="text" ID="A54" class="element text large" size="20">
</td>
</tr>

<tr>
<td>
<label class="description">- Size of largest lymph node involved (mm), specify site:</label>
</td>
<td>
<input type="text" ID="A55" class="element text large" size="20">
</td>
</tr>

<tr>
<td>
<label class="description">- Extranodal extension:</label>
</td>
<td>
	<select class="element select large" ID="A56">
		<option value=""></option>
		<option value="  - Not identified">Not identified</option>
		<option value="  - Present">Present</option>
		<option value="  - Present, extent of ENE, no. < or = 2 mm, no > 2 mm">Present, extent of ENE, no. < or = 2 mm, no > 2 mm</option>
		<option value="  - Cannot be determined">Cannot be determined</option>
	</select>
</td>
</tr>
</table>
</p>
<p>
Approximately 1000 tumor cells are contained in a 3-dimensional 0.2-mm cluster. Thus, if more than 200 individual tumor cells are identified as single dispersed tumor cells or as a nearly confluent elliptical or spherical focus in a single histologic section of a lymph node, there is a high probability that more than 1000 cells are present in the lymph node. In these situations, the node should be classified as containing a micrometastasis (pN1mi). Cells in different lymph node cross-sections or longitudinal sections or levels of the block are not added together; the 200 cells must be in a single node profile even if the node has been thinly sectioned into multiple slices. It is recognized that there is substantial overlap between the upper limit of the ITC and the lower limit of the micrometastasis categories due to inherent limitations in pathologic nodal evaluation and detection of minimal tumor burden in lymph nodes. Thus, the threshold of 200 cells in a single cross-section is a guideline to help pathologists distinguish between these 2 categories. The pathologist should use judgment regarding whether it is likely that the cluster of cells represents a true micrometastasis or is simply a small group of isolated tumor cells.
</p>
</fieldset>
</p>

<p>
<fieldset style="border-color:#e6e6ff;">
	<legend> <label class="description"> Distant Metastasis: </label></legend>

<input class="element checkbox" type="checkbox" id="A72"  value="  - Not applicable"><label class="choice" >Not applicable</label>
<input class="element checkbox" type="checkbox" id="A73"  value="  - Not identified"><label class="choice" >Not identified</label>
<input class="element checkbox" type="checkbox" id="A74"  value="  - Non-regional lymph node(s) (specify):"><label class="choice" >Non-regional lymph node(s) (specify):</label>
<input class="element checkbox" type="checkbox" id="A75"  value="  - Lung (specify):"><label class="choice" >Lung (specify):</label>
<input class="element checkbox" type="checkbox" id="A76"  value="  - Liver (specify):"><label class="choice" >Liver (specify):</label>
<input class="element checkbox" type="checkbox" id="A77"  value="  - Bone (specify):"><label class="choice" >Bone (specify):</label>
<input class="element checkbox" type="checkbox" id="A78"  value="  - Brain (specify):"><label class="choice" >Brain (specify):</label>
<input class="element checkbox" type="checkbox" id="A79"  value="  - Other (specify):"><label class="choice" >Other (specify):</label>
<input class="element checkbox" type="checkbox" id="A80"  value="  - Cannot be determined: "><label class="choice" >Cannot be determined: </label> 

</fieldset>
</p>

<p>
<fieldset style="border-color:#e6e6ff;">
	<legend> <label class="description"> <a href=".\cap\Cancer-Protocols-2022-03-Update\Breast Protocol Folder\Breast.Invasive_4.6.0.0.REL_CAPCP.pdf#page=38" target="_blank">Pathologic Stage Classification (AJCC 8e)</a>:</label></legend>
	
<p>
<table border="1">
<col width="40%">

<tr>
<td  valign="top">
<label class="description">- TNM Descriptors:</label>
</td>
<td>
<input class="element checkbox" type="checkbox" id="A57"  value=" m (multiple foci of invasive carcinoma) "><label class="choice" >m (multiple foci of invasive carcinoma)</label>
<input class="element checkbox" type="checkbox" id="A58"  value=" r (recurrent) "><label class="choice" >r (recurrent)</label>
<input class="element checkbox" type="checkbox" id="A59"  value=" y (post treatment) "><label class="choice" >y (post treatment)</label>
</td>
</tr>

<tr>
<td>
<label class="description">- Primary tumor (pT):</label>
</td>
<td>
	<select class="element select large" ID="A60">
		<option value=""></option>
		<option value="  - pTX:Primary tumor cannot be assessed">pTX:Primary tumor cannot be assessed</option>
		<option value="  - pT0: No evidence of primary tumor">pT0: No evidence of primary tumor</option>
		<option value="  - pTis(DCIS): Ductal carcinoma in situ">pTis(DCIS): Ductal carcinoma in situ</option>
		<option value="  - pTis (Paget): Paget disease of the nipple not associated with invasive carcinoma and/or DCIS in the underlying breast parenchyma">pTis (Paget): Paget disease of the nipple not associated with invasive carcinoma and/or DCIS in the underlying breast parenchyma</option>
		<option value="  - pT1: Tumor < or = 20 mm in greatest dimension">pT1: Tumor < or = 20 mm in greatest dimension</option>
		<option value="  - pT1mi: Tumor < or = 1 mm in greatest dimension">pT1mi: Tumor < or = 1 mm in greatest dimension</option>
		<option value="  - pT1a: Tumor > 1 mm but < or = 5 mm in greatest dimension">pT1a: Tumor > 1 mm but < or = 5 mm in greatest dimension</option>
		<option value="  - pT1b: Tumor > 5 mm but < or = 10 mm in greatest dimension">pT1b: Tumor > 5 mm but < or = 10 mm in greatest dimension</option>
		<option value="  - pT1c: Tumor > 10 mm but < or = 20 mm in greatest dimension">pT1c: Tumor > 10 mm but < or = 20 mm in greatest dimension</option>
		<option value="  - pT2: Tumor > 20 mm but < or = 50 mm in greatest dimension">pT2: Tumor > 20 mm but < or = 50 mm in greatest dimension</option>
		<option value="  - pT3: Tumor > 50 mm in greatest dimension">pT3: Tumor > 50 mm in greatest dimension</option>
		<option value="  - pT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules)">pT4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules)</option>
		<option value="  - pT4a: Extension to the chest wall; invasion or adherence to pectoralis muscle in the absence of invasion of chest wall structures does not qualify as T4">pT4a: Extension to the chest wall; invasion or adherence to pectoralis muscle in the absence of invasion of chest wall structures does not qualify as T4</option>
		<option value="  - pT4b: Ulceration and/or ipsilateral macroscopic satellite nodules and/or edema (including peau d’orange) of the skin that does not meet the criteria for inflammatory carcinoma">pT4b: Ulceration and/or ipsilateral macroscopic satellite nodules and/or edema (including peau d’orange) of the skin that does not meet the criteria for inflammatory carcinoma</option>
		<option value="  - pT4c: Both T4a and T4b are present">pT4c: Both T4a and T4b are present</option>
		<option value="  - pT4d: Inflammatory carcinoma">pT4d: Inflammatory carcinoma</option>
	</select>
</td>
</tr>

<tr>
<td  valign="top">
<label class="description">- Regional lymph nodes modifier: </label>
</td>
<td>
<input class="element checkbox" type="checkbox"  id="A61" value=" sn "><label class="choice" >sn Sentinel node(s) evaluated (< 6 lymph nodes)</label>
<input class="element checkbox" type="checkbox"  id="A62" value=" f  "><label class="choice" >f Nodal metastasis confirmed by FNA or biopsy</label>
</td>
</tr>

<tr>
<td>
<label class="description">
  - Regional lymph nodes (pN): </label>
</td>
<td>
	<select class="element select large" ID="A63">
		<option value=""></option>
		<option value="  - pN not assigned (no nodes submitted or found)">pN not assigned (no nodes submitted or found)</option>
		<option value="  - pN not assigned (cannot be determined based on available pathological information)"> pN not assigned (cannot be determined based on available pathological information)</option>
		<option value="  - pN0: No regional lymph node metastasis or ITCs only">pN0: No regional lymph node metastasis or ITCs only</option>
		<option value="  - pN0(i+): Isolated tumor cells in regional lymph node(s) < or = 0.2 mm">pN0(i+): Isolated tumor cells in regional lymph node(s) < or = 0.2 mm</option>
		<option value="  - pN0(mol+): Positive molecular findings (RT-PCR), but no ITCs detected">pN0(mol+): Positive molecular findings (RT-PCR), but no ITCs detected</option>
		<option value="  - pN1mi: Micrometastases (approximately 200 cells, > 0.2 mm to < or = 2.0 mm)">pN1mi: Micrometastases (approximately 200 cells, > 0.2 mm to < or = 2.0 mm)</option>
		<option value="  - pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis > 2.0 mm">pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis > 2.0 mm</option>
		<option value="  - pN1b: Metastases in ipsilateral internal mammary sentinel nodes, excluding ITCs">pN1b: Metastases in ipsilateral internal mammary sentinel nodes, excluding ITCs</option>
		<option value="  - pN1c: pN1a and pN1b combined">pN1c: pN1a and pN1b combined</option>
		<option value="  - pN2a: Metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit > 2.0 mm)">pN2a: Metastases in 4 to 9 axillary lymph nodes (at least 1 tumor deposit > 2.0 mm)</option>
		<option value="  - pN2b: Metastases in clinically detected internal mammary lymph nodes with or without microscopic confirmation; with pathologically negative axillary nodes">pN2b: Metastases in clinically detected internal mammary lymph nodes with or without microscopic confirmation; with pathologically negative axillary nodes</option>
		<option value="  - pN3a: Metastases in 10 or more axillary lymph nodes (at least 1 tumor deposit > 2.0 mm) or metastases to the infraclavicular (Level III axillary lymph) nodes">pN3a:	Metastases in 10 or more axillary lymph nodes (at least 1 tumor deposit > 2.0 mm) or metastases to the infraclavicular (Level III axillary lymph) nodes</option>
		<option value="  - pN3b: pN1a or pN2a in the presence of cN2b (positive internal mammary nodes by imaging); or pN2a in the presence of pN1b">pN3b: pN1a or pN2a in the presence of cN2b (positive internal mammary nodes by imaging); or pN2a in the presence of pN1b</option>
		<option value="  - pN3c: Metastases in ipsilateral supraclavicular lymph nodes">pN3c: Metastases in ipsilateral supraclavicular lymph nodes</option>
	</select>
</td>
</tr>

<tr>
<td >
<label class="description">- Distant metastasis (pM): </label>
</td>
<td>
	<select class="element select large" ID="A64">
		<option value=""></option>
		<option value="  - Not applicable - pM cannot be determined from the submitted specimen(s)">Not applicable - pM cannot be determined from the submitted specimen(s)</option>
		<option value="  - pM1: Histologically proven metastases larger than 0.2 mm">pM1: Histologically proven metastases larger than 0.2 mm</option>
	</select>
</td>
</tr>

<!--?--
<tr>
<td>
    <label>- Specify site(s), if known:</label>
<input type="text" class="element text medium" ID="A65" size="35">
</td>
</tr>
-->

</table>
</p>
</fieldset>
</p>

<p>
<label class="description">- Additional notes:</label>
<textarea ID="A66" class = "element textarea medium" style="border-color:darkStaleblue;"></textarea>
</p>

<br><br>
<input type="button" name="copyform" value="Check your Report" onclick="updateDescription(this.form)"/>
<br>
<TEXTAREA ID="holdtext" name="holdtext" class="textarea large" style="border-color:coral;"></TEXTAREA>

<br><br>
<!-- The button used to copy the text -->
<button onclick="CopyToClipboard()">Copy text to Clipboard</button>

<input type="reset" value="Reset Form" name="reset" style="float: right;">
</form>
<br>
<br>

<div id="footer">
Last upated on 14-Aug-2024,<br>
based on <a href="https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates" target="_blank">US CAP cancer protocol templates</a>,<br>
Breast Invasive Resection 4.10.0.0 (Jun 2024).<br>
html form was created on 
<a href="https://www.phpform.org">pForm</a>, 
<a href="https://www.w3schools.com/">W3 School</a>, 
<a href="https://stackoverflow.com/">StackOverflow</a>,
 and <a href="https://icons8.com">Icons8</a>.<br><br>
Anatomical Pathology Division, Queen Mary Hospital, Hong Kong.
</div>

</div>

<img id="bottom" src="bottom.png" alt="">
</body>
</html>